| 1 |
32845322 | Human-specific microglial Siglec-11 transcript variant has the potential to affect polysialic acid-mediated brain functions at a distance. | 2021 Apr 1 |
1 |
| 2 |
34060491 | SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection. | 2021 Jun 1 |
1 |
| 3 |
31815204 | Repression of phagocytosis by human CD33 is not conserved with mouse CD33. | 2019 |
3 |
| 4 |
24308974 | Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related Siglecs in primates. | 2014 Mar |
1 |
| 5 |
24216507 | Induction of myelodysplasia by myeloid-derived suppressor cells. | 2013 Nov |
2 |
| 6 |
22500980 | High glucose concentrations induce TNF-α production through the down-regulation of CD33 in primary human monocytes. | 2012 Apr 14 |
1 |
| 7 |
21070233 | Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation? | 2011 Jan |
1 |
| 8 |
17947393 | ITIM-dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, Shp1 and Shp2. | 2008 Jan |
3 |
| 9 |
18062779 | Phosphorylated ITIMs enable ubiquitylation of an inhibitory cell surface receptor. | 2008 Feb |
1 |
| 10 |
17008544 | CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover. | 2007 Feb 1 |
2 |
| 11 |
17138568 | SOCS3 targets Siglec 7 for proteasomal degradation and blocks Siglec 7-mediated responses. | 2007 Feb 9 |
1 |
| 12 |
17580316 | Human-specific expression of Siglec-6 in the placenta. | 2007 Sep |
1 |
| 13 |
16682635 | Loss of Siglec expression on T lymphocytes during human evolution. | 2006 May 16 |
1 |
| 14 |
15454492 | Influence of CD33 expression levels and ITIM-dependent internalization on gemtuzumab ozogamicin-induced cytotoxicity. | 2005 Feb 1 |
2 |
| 15 |
15769739 | Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation. | 2005 May 20 |
1 |
| 16 |
15051513 | Identification of novel CD33 antigen-specific peptides for the generation of cytotoxic T lymphocytes against acute myeloid leukemia. | 2004 Jan |
2 |
| 17 |
15313016 | Sustained stimulation of platelet thrombin receptor is associated with tyrosine dephosphorylation of a novel p67 peptide in a manner regulated by extracellular calcium. | 2004 Aug 23 |
1 |
| 18 |
15331780 | Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms. | 2004 Sep 7 |
1 |
| 19 |
15481154 | Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells. | 2004 |
1 |
| 20 |
15557178 | The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells. | 2004 Dec 1 |
1 |
| 21 |
14617000 | Identification of the CD33-related Siglec receptor, Siglec-5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias. | 2003 Nov |
2 |
| 22 |
11970770 | CD33 as a target for selective ablation of acute myeloid leukemia. | 2002 Mar |
1 |
| 23 |
10887109 | Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2. | 2000 Jul 15 |
3 |
| 24 |
11095983 | Molecular characterization of a Siglec8 variant containing cytoplasmic tyrosine-based motifs, and mapping of the Siglec8 gene. | 2000 Nov 30 |
2 |
| 25 |
10206955 | The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2. | 1999 Apr 23 |
10 |
| 26 |
10338137 | Phosphorylation of p67phox in the neutrophil occurs in the cytosol and is independent of p47phox. | 1999 Apr 23 |
1 |
| 27 |
10556798 | The sialoadhesin CD33 is a myeloid-specific inhibitory receptor. | 1999 Nov |
1 |
| 28 |
9731071 | Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33. | 1998 Sep 15 |
2 |